Joel Kaufman | VP, Finance & Corporate Development |
Katherine Stueland | CEO & Director |
Kevin Feeley | SVP, Operations and Head of GeneDx |
David Delahunt | Goldman Sachs Group |
Matt Kim | Jeffrey |
Max Masucci | Cowen and Company |
Mark Massaro | BTIG |
Good day, and thank you for standing by. Welcome to the Sema4 Second Quarter 2022 Earnings Conference Call. [Operator Instructions]. Please be advised that today's conference may be recorded. I would like to hand the conference over to your speaker today, Joel Kaufman, VP of Finance and Corporate Development.